(1999). Acquisition of plasmin activity by Fusobacterium nucleatum subsp. nucleatum and potential contribution to tissue destruction during periodontitis. Infect Immun
(2000). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontology
(2007). Activation of protective responses in oral epithelial cells by Fusobacterium nucleatum and human betadefensin-2.
(2004). Adenoviral gene delivery of elaﬁn and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inﬂammatory responses of human endothelial cells and macrophages to atherogenic stimuli.
(2008). Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
(2008). an elastase speciﬁc inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic ﬁbrosis.
(1994). and argininespeciﬁc proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins.
(2005). Anti-inﬂammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun
(2000). Anti-inﬂammatory effects of mutant forms of secretory leukocyte protease inhibitor.
(2005). Antimicrobial activity of murine lung cells against Staphylococcus aureus is increased in vitro and in vivo after elaﬁn gene transfer. Infect Immun
(2006). Arginine-speciﬁc gingipains from Porphyromonas gingivalis deprive protective functions of secretory leukocyte protease inhibitor in periodontal tissue. Clin Exp Immunol
(2003). Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol
(2002). Bacteroides forsythus hemagglutinin is inhibited by N-acetylneuraminyllactose. Oral Microbiol Immunol
(1992). Cathepsin B/L-, elastase-, tryptase-, trypsinand dipeptidyl peptidase IV-like activities in gingival crevicular ﬂuid: a comparison of levels before and after periodontal surgery in chronic periodontitis patients.
(2006). Characterization of proteolytic activities of Fusobacterium nucleatum.
(2003). Cloning of the Tannerella forsythensis (Bacteroides forsythus) siaHI gene and puriﬁcation of the sialidase enzyme.
(2000). Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas.
(2002). Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inﬂammatory induction. Cardiovasc Res
(1982). Collagenolytic activity associated with Bacteroides species and Actinobacillus actinomycetemcomitans.
(2009). Corruption of innate immunity by bacterial proteases.
(2009). Degradation of human and -defensins by culture supernatants of Porphyromonas gingivalis strain 381. J Innate Immun
(2000). Development of speciﬁc monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2. Clin Chim Acta
(2009). Elaﬁn is speciﬁcally inactivated by RgpB from Porphyromonas gingivalis by distinct proteolytic cleavage. Biol Chem
(2006). Elaﬁn prevents lipopolysaccharideinduced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway.
(1999). Evidence for excessive bronchial inﬂammation during an acute exacerbation of chronic obstructive pulmonary disease in Effects of periopathogens on host protease inhibitors Citation:
(1998). expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun
(1997). expression, and sequencing of a protease gene from
(2001). Gene expression of human squamous cell carcinoma antigens 1 and 2 in human cell lines. Oncol Rep
(2000). Global epidemiology of periodontal diseases: an overview. Periodontology
(1985). Glycosaminoglycan-depolymerizing enzymes produced by anaerobic bacteria isolated from the human mouth. Arch Oral Biol
(2005). Human immunodeﬁciency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
(2006). Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: synergistic effect of Zn(II). Oral Microbiol Immunol
(2004). Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun
(2008). Involvement of cysteine protease inhibitors in the defense mechanism against parasites. Med Chem
(1998). Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev
(1998). Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun
(2006). Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
(2000). Microbial etiological agents of destructive periodontal diseases. Periodontology
(1999). Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis.
(2008). Multifaceted roles of human elaﬁn and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie
(1998). Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1. J Periodontol
(2000). Novel apoptosis-inducing activity in Bacteroides forsythus: a comparative study with three serotypes of Actinobacillus actinomycetemcomitans. Infect Immun
(2005). Periodontal diseases. Lancet
(2001). Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc
(2006). Porphyromonas gingivalis epithelial cell interactions in periodontitis.
(1999). Porphyromonas gingivalis gingipains and adhesion to epithelial cells. Infect Immun 2001; 69: 304856. Lei Yin et al. (page number not for citation purpose) Citation:
(2002). Proteolysis of CD14 on human gingival ﬁbroblasts by arginine-speciﬁc cysteine proteinases from Porphyromonas gingivalis leading to down-regulation of lipopolysaccharideinduced interleukin-8 production. Infect Immun
(2000). Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness.
(2003). Proteolysis of ICAM-1 on human oral epithelial cells by gingipains. J Dent Res
(2000). Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice ﬂuid. Periodontology
(2009). Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade.
(1992). Puriﬁcation and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis.
(1994). Puriﬁcation and characterization of a novel arginine-speciﬁc cysteine proteinase (argingipain) involved in the pathogenesis of periodontal disease from the culture supernatant of Porphyromonas gingivalis.
(2001). Rapid detection and quantiﬁcation of ﬁve periodontopathic bacteria by real-time PCR. Microbiol Immunol
(2003). Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elaﬁn. Infect Immun
(2000). Regulation of SLPI and elaﬁn release from bronchial epithelial cells by neutrophil defensins.
(2005). Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
(2002). Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.
(2004). Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection.
(2005). Serine proteinase inhibitors in the skin: role in homeostasis and disease. Curr Protein Pept Sci
(2006). Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase.
(2006). SLPI and elaﬁn: one glove, many ﬁngers. Clin Sci (Lond)
(1997). Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase.
(2003). Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-speciﬁc antibiotic elaﬁn in human keratinocytes. Exp Dermatol
(2003). The relationship between periodontal diseases and respiratory diseases. Dent Today
(2004). The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1.
(2000). TNF-alpha and serum induce SKALP/elaﬁn gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway. Arch Dermatol Res
(2000). Virulence factors of Porphyromonas gingivalis. Periodontology